TYROGEF 250MG TABLET Substitute
Composition:
GEFITINIB-250MG
Uses:
Treatment of Non-small cell lung cancer
Medicinal Benefits:
TYROGEF 250MG TABLET is indicated to the patients dealing with non-small cell lung cancer. Cancer of this type tends to spread quickly in other parts of the body. TYROGEF 250MG TABLET travels through the bloodstream and effectively destroys cancerous cells of the lung and other parts of the body. TYROGEF 250MG TABLET is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. It acts by stopping the abnormal protein action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so TYROGEF 250MG TABLET targets cancerous cells and blocks the action of Tyrosine kinase enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, TYROGEF 250MG TABLET stops the production, spread and growth of cancerous cells in the body.
TYROGEF 250MG TABLET is used to treat non-small cell lung cancer.
TYROGEF 250MG TABLET works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. Thereby, it prevents the spread of cancerous cells.
The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer followed by coughing.
It is suggested to avoid taking an antacid or stomach acid-reducing medicine within 6 hours after taking TYROGEF 250MG TABLET as it may make the medicine less effective if taken simultaneously.
TYROGEF 250MG TABLET is safe to be taken by a diabetic person. However, take TYROGEF 250MG TABLET only after asking a doctor as they may adjust the dosing according to the patient's condition.